In some reports on the final results I have found the following statement and I wonder why so many people obviously died after 8.4 years when the data after 7 years were so good: "A total of 740 patients were treated with T-DM1, and 720 were treated with trastuzumab. At the 8.4-year follow-up mark, 521 (70.1%) and 461 (62.0%) in the T-DM1 and trastuzumab arms, respectively were still alive." Can anyone explain the discrepancy?
👍🏻👍🏻👍🏻👍🏻
In some reports on the final results I have found the following statement and I wonder why so many people obviously died after 8.4 years when the data after 7 years were so good: "A total of 740 patients were treated with T-DM1, and 720 were treated with trastuzumab. At the 8.4-year follow-up mark, 521 (70.1%) and 461 (62.0%) in the T-DM1 and trastuzumab arms, respectively were still alive." Can anyone explain the discrepancy?